The invention is concerned with novel cycloalkane carboxamides of Formula (I)wherein X, X, Y, Y, R,R, R, R, m and n are as defined in the descriptionand in the claims, as well as physiologically acceptable salts thereof. Thesecompounds inhibit the coagulation factor Xa and can be used as medicaments.